Nar­can mak­er Opi­ant shelves bu­lim­ia pro­gram af­ter mid-stage flop

Nar­can mak­er Opi­ant Phar­ma­ceu­ti­cals has ad­mit­ted de­feat in a mid-stage tri­al test­ing a nasal spray ver­sion of nalox­one in pa­tients with bu­lim­ia, prompt­ing the Cal­i­for­nia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER